William Lewis Insmed Inc (INSM) insider trading activity

William Lewis is Chair and CEO of INSMED Inc. Currently has a direct ownership of 303,554 shares of INSM, which is worth approximately $29.6 Million. The most recent transaction as insider was on Jun 16, 2025, when has been sold 5,204 shares (Common Stock) at a price of $100.06 per share, resulting in proceeds of $520,712. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 304K

9.17% 3M change

20.98% 12M change

Total Value Held $29.6 Million

William Lewis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 16 2025	SELL Open market or private sale	$520,712 $100.06 p/Share	5,204 Reduced 1.69%	303,554 Common Stock
Jun 03 2025	SELL Open market or private sale	$391,248 $71.5 p/Share	5,472 Reduced 1.74%	308,758 Common Stock
May 20 2025	SELL Open market or private sale	$1,427,032 $67.77 p/Share	21,057 Reduced 6.28%	314,230 Common Stock
May 15 2025	BUY Grant, award, or other acquisition	-	22,314 Added 6.24%	335,287 Common Stock
May 14 2025	SELL Open market or private sale	$247,415 $65.61 p/Share	3,771 Reduced 1.19%	312,973 Common Stock
May 13 2025	SELL Open market or private sale	$1,169,486 $67.05 p/Share	17,442 Reduced 5.22%	316,744 Common Stock
Mar 17 2025	SELL Open market or private sale	$1,441,125 $76.86 p/Share	18,750 Reduced 5.31%	334,186 Common Stock
Mar 17 2025	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 5.04%	352,936 Common Stock
Mar 03 2025	SELL Open market or private sale	$1,473,562 $78.59 p/Share	18,750 Reduced 5.31%	334,186 Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 5.04%	352,936 Common Stock
Feb 18 2025	SELL Open market or private sale	$1,516,875 $80.9 p/Share	18,750 Reduced 5.31%	334,186 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 5.04%	352,936 Common Stock
Feb 06 2025	SELL Open market or private sale	$6,419,415 $80.9 p/Share	79,350 Reduced 14.88%	453,894 Common Stock
Feb 05 2025	BUY Grant, award, or other acquisition	-	153,710 Added 22.38%	533,244 Common Stock
Feb 03 2025	SELL Open market or private sale	$1,443,750 $77.0 p/Share	18,750 Reduced 4.71%	379,534 Common Stock
Feb 03 2025	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 4.5%	398,284 Common Stock
Jan 15 2025	SELL Open market or private sale	$2,234,301 $70.25 p/Share	31,805 Reduced 7.73%	379,534 Common Stock
Jan 15 2025	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 4.36%	411,339 Common Stock
Jan 10 2025	SELL Open market or private sale	$188,686 $63.36 p/Share	2,978 Reduced 0.75%	392,589 Common Stock
Jan 08 2025	SELL Open market or private sale	$263,774 $65.96 p/Share	3,999 Reduced 1.06%	372,743 Common Stock
Jan 08 2025	BUY Grant, award, or other acquisition	-	22,824 Added 5.46%	395,567 Common Stock
Jan 07 2025	SELL Open market or private sale	$542,552 $66.02 p/Share	8,218 Reduced 2.13%	376,742 Common Stock
Jan 02 2025	SELL Open market or private sale	$1,309,500 $69.84 p/Share	18,750 Reduced 4.64%	384,960 Common Stock
Jan 02 2025	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 4.44%	403,710 Common Stock
Dec 19 2024	SELL Open market or private sale	$1,314,000 $70.08 p/Share	18,750 Reduced 4.64%	384,960 Common Stock

Also insider at

NAMS

NewAmsterdam Pharma Co N.V.

William Lewis

Chair and CEO

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Value

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to INSMED Inc

Track Activities on INSM

Account